In the present study, we found that DX1, a re-engineered fragment of a lupus autoantibody that penetrates cells in an ENT2-dependent manner, crosses an intact BBB in a transwell model and localizes to and suppresses the growth of tumors in orthotopic GBM and brain metastasis models. The gene discussed is SLC29A2; the disease is glioblastoma.